Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 4 October

Grady Wulff
October 4, 2023

Morning Bell 3 October

Sam Kanaan
October 3, 2023

Morning Bell 2 October

Grady Wulff
October 2, 2023

Weekly Wrap 29 September

Grady Wulff
September 29, 2023

Morning Bell 29 September

Sam Kanaan
September 29, 2023

Morning Bell 28 September

Grady Wulff
September 28, 2023

Morning Bell 27 September

Grady Wulff
September 27, 2023

Morning Bell 26 September

Sam Kanaan
September 26, 2023

Morning Bell 25 September

Grady Wulff
September 25, 2023

Morning Bell 22 September

Sam Kanaan
September 22, 2023

Morning Bell 21 September

Sophia Mavridis
September 21, 2023

Morning Bell 20 September

Sam Kanaan
September 20, 2023